Drug development is a long and expensive process. The article lays out several steps that researchers may take in the early stages of clinical trials to make the process faster, more efficient, and potentially less costly, while minimizing the risk of "surprises" later on in development. Some of the proposed solutions are counterintuitive, but the source explained the rationale for them and their potential value.
See the contest questionnaire in which the reporter writes about how this story was written.